Assessing miR-146a-5P with IL-6 and TLR-4 serum levels in diabetic mellitus patients with or without urinary tract infection
Keywords:Diabetic mellitus, UPEC, IL-6, TLR-4, miR-146a-5p
Introduction and Aim: Diabetes is a chronic metabolic disease that affects glucose levels. This condition increases blood sugar and weakens immunity, damaging neutrophil function and urine antibacterial activity. IL-6 and TLR-4 are involved in inflammation and immune system control, while miR-146-5p may be a biomarker for diabetes. This study examines IL-6, TLR-4, and miR-146-5p in diabetics with and without UT infection.
Materials and Methods: In this study, blood samples were collected from 100 diabetic mellitus patients suffering from UTI in addition to 100 individuals apparently healthy as control. The serum levels of IL-6 and TLR-4 were detected using commercial BTlab brand ELISA kits. The plasma RNA expression level of the miR-146a-5p was determined by real time-PCR using a specific primer for miR-146a-5p with the U6 gene utilized as a reference gene.
Results: The results showed that diabetic patient’s group had a significantly higher response of IL-6 than controls (75.6 vs. 27.6). TLR-4 levels showed high levels in diabetic patients’ group (1.3) in comparison with the control group (0.441). Both IL-6 and TLR-4 levels showed a significant difference between the diabetic patients with UTI compared to control. The results revealed no-significant differences in the levels among both diabetic patients with UTI and patients without UTI. TLR-4 and IL-6 showed a significant inverse relationship while the relation between TLR-4 level and miR-146a-5p expression level showed a negative relationship.
Conclusion: The levels of IL-6, TLR-4, and miR-146-5p expression were found to be considerably greater in individuals with diabetes having UTIs compared to patients with diabetes alone. An inverse relationship existed between IL-6 and TLR-4 levels as well as between TLR-4 and miR-146a-5p. The expression levels of IL-6 and miR-146-5p were nearly equal.
Mikhael, E.M., Hassali, M.A., Hussain, S.A., Shawky, N. Self-management knowledge and practice of type 2 diabetes mellitus patients in Baghdad, Iraq: A qualitative study. Diabetes Metab Syndr Obes. 2018;12:1-17.
Vijayashankar, U., Rajalakshmi, R., Ramya, C.M., Kumar, B., Smitha, M.C. Effect of lifestyle intervention in Type II diabetes. Biomedicine. 2022 Jul 3;42(3):550-555.
Adu, M., Malibu, U., Malau-Aduli, A., Malau-Aduli, B. Enablers and barriers to effective diabetes self-management: A multi-national investigation. PLoS One. 2019;14(6): e0217771
Ahmed, A.G., Al Atrakji, M.Q., Alwattar, W.M. Antibacterial effect of ethanolic fraction of Medicago sativa extract on Escherichia coli in urinary tract infection. Biomedicine. 2023 May 4;43(02):655-659.
Ogaidi B., AL-Jobori, K., Ghareeb, A. Green synthesis of silver nanoparticles by Ricinus communis and investigate its antibacterial potential against methicillin-resistant Staphylococcus aureus (MRSA). Biochemical and Cellular Archives. 2021; 21(2):3731-3740.
Mohsin, M.R., AL-Rubaii, B.A. Bacterial growth and antibiotic sensitivity of Proteus mirabilis treated with anti-inflammatory and painkiller drugs. Biomedicine. 2023;43(2): 728-734.
Worku, G., Alamneh, Y., Abegaz, W. Prevalence of bacterial urinary tract infection and antimicrobial susceptibility patterns among diabetes mellitus patients attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia.Infect Drug Resist. 2021;14: 1441-1454
Forson, A., Menkah, D., Quarchie, M., Dhikrullah, S., Olu-Taiwo, M., Codjoe F. Bacterial drug-resistance patterns and genetic diversity of bacteria-associated bacteriuria in diabetic patients in Ghana. IJID Regions. 2021; 1:142-149.
Berbudi, A., Rahmadika, N., Tjahjadi, A., Ruslami, R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2021; 16(5):442-449.
Rasoulinejad, S., Akbari, A., Nasiri, K. Interaction of miR-146a-5p with oxidative stress and inflammation in complications of type 2 diabetes mellitus in male rats: Antioxidant and anti-inflammatory protection strategies in type 2 diabetic retinopathy. Iran J Basic Med Sci. 2021;24 (8):1078-1086.
Wang, X., Sundquist, J., Zöller, B. Role of miRNAs in the development and progression of type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews. 2018;34(7): e2994.
Villar-Fincheira, P., Sanhueza-Olivares, F., Norambuena-Soto, I., Cancino-Arenas, N., Hernandez-Vargas, F., Troncoso, R., et al., Role of Interleukin-6 in vascular health and disease. Front Mol Biosci. 2021;8: 641734.
Wang, S., Yang, Y., Suen, A., Zhu, J., Williams, B., Hu, J., et al., Role of extracellular microRNA-146a-5p in host innate immunity and bacterial sepsis. Iscience. 2021; 24(12). 103441.
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., et al., Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature.2013; 458(7242): 1185-1190.
Mohammed, A.M., Zayni, S.M., AL-Anee, M.M., Corial, F.I.,Al-Rubaee, A. Diagnostic and predictive values of IL-6 in a group of Iraqi patients with rheumatoid arthritis. Journal of the Faculty of Medicine Baghdad. 2023; 65(2):116-121.
Aboudounya, M., Heads R. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyper inflammation. Mediators Inflamm. 2021; 2021: 1-8.
Litak, J., Grochowski, C., Litak, J., Osuchowska, I., Gosik, K., Radzikowska, E., et al., TLR-4 Signaling vs. immune checkpoints, mirnas molecules, cancer stem cells, and wingless-signaling interplay in glioblastoma multiforme—Future Perspectives. International Journal of Molecular Sciences. 2020; 21(9): 3114.
Taganov, K., Boldin, M., Chang, K., Baltimore, D. NF-B-dependent induction of microRNA miR-146,an inhibitor targeted to signaling proteins of innate immune responses. PNAS. 2006;103(33):12481-12486.
Asmaa A. Muhaimeed, Abdulameer M. Ghareeb Prevalence of multi-antibiotic resistance marA and quorum sensing luxS genes and evaluation of biofilm formation in uropathogenic Escherichia coli. Iraqi Journal of Biotechnology. 2023; 22(1): 252-261.
Daryabor, G., Atashzar, M., Kabelitz, D., Meri S., Kalantar, K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 2020;11: 1582.
Patil, S., Gondhali, G., Acharya, A. Role of initial and follow-up IL-6 (Interleukin-6) titre in COVID-19 pneumonia: A single center experience. Electronic Journal of General Medicine. 2022; 19(5): em390.
Oliveira, F., Bafica, A., Rosato, A.B., Favali, C.B., Costa, J.M., Cafe, V., et al., Lesion size correlates with leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg. 2011; 85(1):70-73.
Vázquez-Carballo, C., Guerrero-Hue, M., García-Caballero, C., Rayego-Mateos, S., Opazo-Ríos, L., Morgado-Pascual, J.L. et al., Toll-like receptors in acute kidney injury. International Journal of Molecular Sciences. 2021; 22(2): 816.
El-Mesallamy, H.O., Diab, M.R., Hamdy, N.M., Dardir, S.M. Cell-based regenerative strategies for treatment of diabetic skin wounds, a comparative study between human umbilical cord blood-mononuclear cells and calves' blood haemodialysate. PLoS ONE. 2014; 9(3): e89853.
Barutta, F., Corbetta, B., Bellini, S., Guarrera, S., Matullo, G., Scandella, M. et al., MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS. J Transl Med. 2021; 19(1):1-10.
El-Hini, S., El-Akad, A., Nagib, M. Study the level of micro RNA146 a in human serum in the diabetic patients. MJMR. 2020; 31(2): 184-188.
Abdul-Rahman, P. S., Lim, P. S., Hashim, O. H., Shuib, A. S. Activation of TLR4-dependent inflammatory pathway in type 2 diabetes mellitus: the effect of metformin. Journal of Inflammation Research. 2020; 13: 1239-1251.
Zhang, J., Wang, X., Zhang, Y., Yang, X., Liu, Y., Xu, Y. The role of TLR4 and IL-6 in patients with urinary tract infections. Journal of Clinical Laboratory Analysis. 2019; 33(5):e22843.
Kim, Y. H., Kwon, Y. S., Oh, D. H., Kim, K. S. Urinary toll-like receptor 4 and inflammatory cytokines in patients with acute pyelonephritis. Journal of Microbiology, Immunology, and Infection. 2016; 49(5):699-706.
How to Cite
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.